UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report

Diagnostic pathology, 2024-01, Vol.19 (1), p.16-16, Article 16

2024

Volltextzugriff (PDF)

Novel diagnostic biomarkers for pancreatic cancer: assessing methylation status with epigenetic-specific peptide nucleic acid and KRAS mutation in cell-free DNA

Frontiers in oncology, 2024-07, Vol.14, p.1395473

2024

Volltextzugriff (PDF)

Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma

Hepatobiliary & pancreatic diseases international, 2020-02, Vol.19 (1), p.41-50

2020

Volltextzugriff (PDF)

EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors

Cancer research and treatment, 2018-07, Vol.50 (3), p.908-916

2018

Volltextzugriff (PDF)

Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study

Therapeutic advances in medical oncology, 2024-01, Vol.16, p.17588359241265209

2024

Volltextzugriff (PDF)

Discordance in HER2 status between primary gastric adenocarcinoma tumors and cells from the corresponding malignant effusions

BMC cancer, 2019-09, Vol.19 (1), p.834-834, Article 834

2019

Volltextzugriff (PDF)

Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy

Journal of translational medicine, 2021-01, Vol.19 (1), p.7-7, Article 7

2021

Volltextzugriff (PDF)

Diagnostic Value of Ascitic Tumor Markers for Gastric Cancer-associated Malignant Ascites

Korean Journal of Helicobacter Upper Gastrointestinal Research , 2022, 22(1), , pp.38-49

2022

Volltextzugriff (PDF)

Exosomal miR-181b-5p Downregulation in Ascites Serves as a Potential Diagnostic Biomarker for Gastric Cancer-associated Malignant Ascites

Journal of Gastric Cancer, 2019, 19(3), , pp.301-314

2019

Volltextzugriff (PDF)

Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)

Therapeutic advances in medical oncology, 2021-12, Vol.13, p.17588359211061989-17588359211061989

2021

Volltextzugriff (PDF)

Collision tumor comprising metastatic cholangiocarcinoma and seminoma in an undescended testis: a case report

Journal of international medical research, 2019-11, Vol.47 (11), p.5809-5816

2019

Volltextzugriff (PDF)

Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy

Journal of cancer research and clinical oncology, 2016-03, Vol.142 (3), p.707-714

2016

Volltextzugriff (PDF)

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

The New England journal of medicine, 2020-06, Vol.382 (25), p.2419-2430

2020

Volltextzugriff (PDF)

Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma

Clinical cancer research, 2021-10, Vol.27 (19), p.5272-5279

2021

Volltextzugriff (PDF)

AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells

Molecular cancer therapeutics, 2017-04, Vol.16 (4), p.566-577

2017

Volltextzugriff (PDF)

E-Cadherin and Angiopoietin-2 as Potential Biomarkers for Colorectal Cancer With Peritoneal Carcinomatosis

Anticancer research, 2021-09, Vol.41 (9), p.4497-4504

2021

Volltextzugriff (PDF)

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)

European journal of cancer (1990), 2021-11, Vol.157, p.21-30

2021

Volltextzugriff (PDF)

ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17)

Journal of clinical oncology, 2024-06, Vol.42 (16_suppl), p.3050-3050

2024

Volltextzugriff (PDF)

The new diagnostic criteria for myelodysplasia-related acute myeloid leukemia is useful for predicting clinical outcome: comparison of the 4th and 5th World Health Organization classifications

Annals of hematology, 2022-12, Vol.101 (12), p.2645-2654

2022

Volltextzugriff (PDF)

Metastatic Adrenocortical Carcinoma Presenting Simultaneously with Cushing's and Conn's Syndromes: A Case Report

Japanese journal of clinical oncology, 2011-11, Vol.41 (11), p.1287-1291

2011

Volltextzugriff (PDF)

Abstract 3815: Overcoming acquired resistance of Lapatinib in breast cancer with Palbociclib

Cancer research (Chicago, Ill.), 2019-07, Vol.79 (13_Supplement), p.3815-3815

2019

Volltextzugriff (PDF)

Anti‐tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells

International journal of cancer, 2017-01, Vol.140 (1), p.109-119

2017

Volltextzugriff (PDF)

Androgen Receptor Inhibitor Enhances the Antitumor Effect of PARP Inhibitor in Breast Cancer Cells by Modulating DNA Damage Response

Molecular cancer therapeutics, 2018-12, Vol.17 (12), p.2507-2518

2018

Volltextzugriff (PDF)

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3)

Journal of clinical oncology, 2021-05, Vol.39 (15_suppl), p.4119-4119

2021

Volltextzugriff (PDF)

Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors

Cancer immunology research, 2016-03, Vol.4 (3), p.215-224

2016

Volltextzugriff (PDF)

1 – 25 von 70

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(63)
Mit Volltextzugriff
(65)

Publikationsform

Artikel
(67)
Berichte
(3)

Sprache

Englisch
(68)
Koreanisch
(2)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Epithelioid angiomyolipoma of the liver in a patient with Li-Fraumeni syndrome: a case report

Novel diagnostic biomarkers for pancreatic cancer: assessing methylation status with epigenetic-specific peptide nucleic acid and KRAS mutation in cell-free DNA

Bile-derived circulating extracellular miR-30d-5p and miR-92a-3p as potential biomarkers for cholangiocarcinoma

EGFR Mutation Status in Lung Adenocarcinoma-Associated Malignant Pleural Effusion and Efficacy of EGFR Tyrosine Kinase Inhibitors

Efficacy of ferric carboxymaltose or darbepoetin alfa for chemotherapy-induced anemia in patients with esophagogastric or pancreaticobiliary cancer: a retrospective comparative study

Discordance in HER2 status between primary gastric adenocarcinoma tumors and cells from the corresponding malignant effusions

Genomic profile of metastatic breast cancer patient-derived xenografts established using percutaneous biopsy

Diagnostic Value of Ascitic Tumor Markers for Gastric Cancer-associated Malignant Ascites

Exosomal miR-181b-5p Downregulation in Ascites Serves as a Potential Diagnostic Biomarker for Gastric Cancer-associated Malignant Ascites

Phase II study of DHP107 (oral paclitaxel) in the first-line treatment of HER2-negative recurrent or metastatic breast cancer (OPTIMAL study)

Collision tumor comprising metastatic cholangiocarcinoma and seminoma in an undescended testis: a case report

Prognostic implication of serum hepatocyte growth factor in stage II/III breast cancer patients who received neoadjuvant chemotherapy

Trastuzumab Deruxtecan in Previously Treated HER2-Positive Gastric Cancer

Randomized Phase II Study of Axitinib versus Observation in Patients with Recurred or Metastatic Adenoid Cystic Carcinoma

AZD6738, A Novel Oral Inhibitor of ATR, Induces Synthetic Lethality with ATM Deficiency in Gastric Cancer Cells

E-Cadherin and Angiopoietin-2 as Potential Biomarkers for Colorectal Cancer With Peritoneal Carcinomatosis

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in gemcitabine-failed metastatic pancreatic cancer patients: A randomised controlled trial (MPACA-3)

ctDNA as a biomarker in phase II study of tepotinib in advanced solid cancers with MET exon 14 skipping mutation or amplification (KCSG AL19-17)

The new diagnostic criteria for myelodysplasia-related acute myeloid leukemia is useful for predicting clinical outcome: comparison of the 4th and 5th World Health Organization classifications

Metastatic Adrenocortical Carcinoma Presenting Simultaneously with Cushing's and Conn's Syndromes: A Case Report

Abstract 3815: Overcoming acquired resistance of Lapatinib in breast cancer with Palbociclib

Anti‐tumor activity of the ATR inhibitor AZD6738 in HER2 positive breast cancer cells

Androgen Receptor Inhibitor Enhances the Antitumor Effect of PARP Inhibitor in Breast Cancer Cells by Modulating DNA Damage Response

Modified FOLFIRINOX versus S-1 as second-line chemotherapy in patients with gemcitabine-failed metastatic pancreatic cancer: A randomized phase III trial (MPACA-3)

Phase I Study of Random Healthy Donor-Derived Allogeneic Natural Killer Cell Therapy in Patients with Malignant Lymphoma or Advanced Solid Tumors

Suchergebnisse filtern